Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hofsli

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 10, 1992
[Multiple drug resistance--theoretical and clinical aspects]E Hofsli
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 10, 1991
[Therapeutic failure of antineoplastic agents. Extracellular and cellular causes]E Hofsli
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 20, 1991
[Interleukins--important signal substances for T-lymphocytes]E Hofsli
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Effect of pyridoxine on tumor necrosis factor activities in vitroE Hofsli, A Waage
International Journal of Cancer|July 15, 1989
Reversal of drug resistance by erythromycin: erythromycin increases the accumulation of actinomycin D and doxorubicin in multidrug-resistant cellsE Hofsli, J Nissen-Meyer
Scandinavian Journal of Immunology|January 1, 1989
Recombinant tumour necrosis factor (TNF) fixed to cell monolayers retains its cytotoxic and growth-stimulatory activity. Evidence that internalization of TNF is not necessary for induction of biological effectsE Hofsli, J Nissen-Meyer
Cancer Research|July 1, 1990
Reversal of multidrug resistance by lipophilic drugsE Hofsli, J Nissen-Meyer
International Journal of Cancer|March 15, 1989
Effect of erythromycin and tumour necrosis factor on the drug resistance of multidrug-resistant cells: reversal of drug resistance by erythromycinE Hofsli, J Nissen-Meyer
Scandinavian Journal of Immunology|October 1, 1988
Evidence that tumour necrosis factor (TNF) is not constitutively present in vivo. The association of TNF with freshly isolated monocytes reflects a rapid in vitro productionE Hofsli, J Lamvik, J Nissen-Meyer
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 20, 1988
[Tumor necrosis factor]A Waage, R Austgulen, E Hofsli, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 10, 1992
[Multiple drug resistance--theoretical and clinical aspects]E Hofsli
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 10, 1991
[Therapeutic failure of antineoplastic agents. Extracellular and cellular causes]E Hofsli
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 20, 1991
[Interleukins--important signal substances for T-lymphocytes]E Hofsli
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Effect of pyridoxine on tumor necrosis factor activities in vitroE Hofsli, A Waage
International Journal of Cancer|July 15, 1989
Reversal of drug resistance by erythromycin: erythromycin increases the accumulation of actinomycin D and doxorubicin in multidrug-resistant cellsE Hofsli, J Nissen-Meyer
Scandinavian Journal of Immunology|January 1, 1989
Recombinant tumour necrosis factor (TNF) fixed to cell monolayers retains its cytotoxic and growth-stimulatory activity. Evidence that internalization of TNF is not necessary for induction of biological effectsE Hofsli, J Nissen-Meyer
Cancer Research|July 1, 1990
Reversal of multidrug resistance by lipophilic drugsE Hofsli, J Nissen-Meyer
International Journal of Cancer|March 15, 1989
Effect of erythromycin and tumour necrosis factor on the drug resistance of multidrug-resistant cells: reversal of drug resistance by erythromycinE Hofsli, J Nissen-Meyer
Scandinavian Journal of Immunology|October 1, 1988
Evidence that tumour necrosis factor (TNF) is not constitutively present in vivo. The association of TNF with freshly isolated monocytes reflects a rapid in vitro productionE Hofsli, J Lamvik, J Nissen-Meyer
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 20, 1988
[Tumor necrosis factor]A Waage, R Austgulen, E Hofsli, et al.
Pageof 3